Lung cancer, Interstitial pneumonia
Conditions
Interventions
None listed
Sponsors
Nagasaki University Hospital, Second Department of Internal Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Lung cancer patients performed chemotherapy in study entry facilities during from April 1, 2013 to March 31, 2016.
Exclusion criteria
Exclusion criteria: Refusal by the notices to the Internet, patients that the later information was not provided by changing hospital enough, in addition, patients whom researchers judged to be inappropriate as a study subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of the frequency of the chemotherapy induced aggravation of interstitial pneumonia between patients with interstitial shadow and without the shadow. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of the interstitial shadow in lung cancer patients performed chemotherapy, prognostic difference between with or without interstitial shadow, rate of concordance in observers about an evaluation of the interstitial shadow, rate of concordance of conventional HRCT score, Goddard classification and the evaluation in Lung Vision | — |
Countries
Japan
Contacts
Public ContactHiroshi Gyotoku
Nagasaki University Hospital Second Department of Internal Medicine
Outcome results
None listed